Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-25-003516
Filing Date
2025-03-28
Accepted
2025-03-28 13:53:16
Documents
132
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F qntm_20f.htm   iXBRL 20-F 3213471
2 DESCRIPTION OF SECURITIES qntm_ex21.htm EX-2.1 41859
3 FORM OF CONVERTIBLE DEBENTURES qntm_ex22.htm EX-2.2 144834
4 FORM OF CLASS B COMMON STOCK PURCHASE WARRANTS qntm_ex23.htm EX-2.3 128141
5 SHAREHOLDER AGREEMENT qntm_ex422.htm EX-4.22 87905
6 FORM OF SECURED CONVERTIBLE DEBENTURES qntm_ex423.htm EX-4.23 137356
7 FORM OF GENERAL SECURITY AGREEMENT qntm_ex424.htm EX-4.24 157612
8 FORM OF AGENCY AND INTERLENDER AGREEMENT qntm_ex425.htm EX-4.25 116184
9 LIST OF SUBSIDIARIES qntm_ex81.htm EX-8.1 9029
10 INSIDER TRADING AND BLACKOUT PERIOD POLICY qntm_ex111.htm EX-11.1 72678
11 CERTIFICATION qntm_ex121.htm EX-12.1 9251
12 CERTIFICATION qntm_ex122.htm EX-12.2 9340
13 CERTIFICATION qntm_ex131.htm EX-13.1 4442
14 CERTIFICATION qntm_ex132.htm EX-13.2 3818
15 MDA qntm_ex151.htm EX-15.1 852588
16 CONSENT OF INDEPENDENT AUDITOR qntm_ex152.htm EX-15.2 1106
17 QUANTUM BIOPHARMA LTD. CLAWBACK POLICY qntm_ex971.htm EX-97.1 51745
23 qntm_ex111img2.jpg GRAPHIC 7484
24 qntm_20fimg3.jpg GRAPHIC 25586
25 qntm_20fimg2.jpg GRAPHIC 28690
26 qntm_ex152img184.jpg GRAPHIC 114469
  Complete submission text file 0001654954-25-003516.txt   13620544

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA fsd-20241231.xsd EX-101.SCH 142197
19 XBRL TAXONOMY EXTENSION LABEL LINKBASE fsd-20241231_lab.xml EX-101.LAB 519368
20 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fsd-20241231_cal.xml EX-101.CAL 76353
21 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fsd-20241231_pre.xml EX-101.PRE 433298
22 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fsd-20241231_def.xml EX-101.DEF 241095
135 EXTRACTED XBRL INSTANCE DOCUMENT qntm_20f_htm.xml XML 2386921
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39152 | Film No.: 25784335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)